Signal transduction

Signal transduction converts a detected signal into a change inside a biological cell. For chemical signals, distinguish reception by a receptor, intracellular signal transduction, and the response: altered gene expression, enzyme activity or ion channel opening, for example. A cell-surface receptor can relay a ligand's presence across a cell membrane without the ligand entering the cytoplasm. Thus a hydrophilic signal need not cross the membrane to influence the interior. See Clark, Douglas and Choi, Biology 2e, 9.2: intracellular signal propagation.

For a computed example of possible signal amplification, suppose one activated receptor activates five relay proteins, and each relay activates twenty target proteins during a chosen interval. If the targets are distinct and available, $1\times 5\times 20=100$ targets are activated. Those assumed counts illustrate multiplication, not a measured pathway or a universal gain. Actual signal transduction can branch, saturate or inhibit activity. Changes in gene expression and changes in existing enzyme activity are different responses. See Clark, Douglas and Choi, Biology 2e, 9.3: cellular responses.

Signal amplification, signaling feedback and signaling adaptation are possible properties of signal transduction, rather than requirements of every cascade. Intracellular relays can use proteins or second messengers; different biological cells can interpret the same ligand differently because they contain different receptors and relay machinery. The useful and striking idea is that recognition and response are separable: an extracellular chemical message can control many internal tasks without itself performing those tasks. See General Principles of Cell Communication.

An original experimental route to this separation appears in T. W. Rall and Earl W. Sutherland's 1958 work on cAMP. They described a heat-stable factor formed from ATP in separated biological cell preparations; it affected enzyme activity in other preparations where the initiating chemical signals had no direct effect. This helped distinguish an initial signal from a molecule carrying its effect to another target. ^[ref]

A member of the CLAVATA3-EMBRYO SURROUNDING REGION-related peptide family. Selected root-produced CLE peptides participate in autoregulation of nodulation; the family has many other developmental functions.

A partly shared plant signaling route used in arbuscular mycorrhizal and root-nodule symbioses. Nuclear calcium oscillations and CCaMK are central elements; partner-specific reception and downstream programs remain distinct.

A rhizobial lipochitooligosaccharide signal recognized by compatible host receptors during many legume symbioses. Recognition does not by itself establish effective nitrogen fixation.

Regulation by changes in free intracellular calcium ion concentration. Calcium signatures are interpreted through calcium-binding sensors and downstream targets; calcium concentration is not itself the final response.

Calcium-induced calcium release is activation of release from an intracellular calcium store by cytoplasmic calcium itself. A two-pool model can represent the release flux as a product of saturating functions of store and cytoplasmic concentrations. Together with uptake, leakage and external calcium balance, this positive feedback can generate excitability or sustained oscillation; the existence of oscillation still depends on the full dynamical parameters.

A two-pool calcium model couples cytosolic calcium and an intracellular store. With compatible reference volumes, uptake $J_{+}$ moves calcium into the store, release $J_{-}$ and leakage $k_s{c}_s$ return it, and ${\dot{c}}_s=J_{+}-J_{-}-k_s{c}_s$. External supply $r$ and export $kc$ give $d(c+c_s)/dt=r-kc$. Thus an equilibrium has $c=r/k$ independently of the internal exchange law. Distinct physical reference volumes require their appropriate volume factors before adding the balances.

The unique equilibrium has $u=\mu$ and $f=0$. Its determinant is $-f_v/ϵ>0$ and trace is $-1+(f_v-\gamma f_u)/ϵ$. Thresholds are obtained from the two displayed equations, and a positive-trace interval exists only if the fast normal derivative rises above $ϵ$. At a nondegenerate trace crossing, the linear oscillation frequency is $\sqrt{-f_v/ϵ}$. The sign of a nonlinear Hopf coefficient is needed to classify the local periodic branch; in a bounded positive planar flow, a unique repelling equilibrium also allows a Poincaré-Bendixson existence argument for a periodic orbit.

For $J=\beta u^2/(1+u^2)$ and $K=u^4/(1+u^4)$ with small leak $\delta$, the positive nullcline is unique at each $u$ because its derivative with respect to $v$ is strictly negative. Its asymptotic regions are a high-store balance $v\simeq (J-K)/\delta$, a crossing balance near $J(u_c)=K(u_c)$, and a negligible-leak balance $v^2/(1+v^2)\simeq J/K$. The crossing relation is $(K_c^{\prime }-J_c^{\prime })(u-u_c)\simeq K_c/v^2-\delta v$. These describe one continuous curve, not three distinct equilibria at a fixed cytoplasmic concentration.

For $\dot{u}=\mu -u-\gamma f/ϵ$ and $\dot{v}=f/ϵ$, total scaled calcium $w$ changes only on the external-input/extrusion time scale. Fast motion therefore follows lines $u+\gamma v=\mathrm{constant}$. The fast normal eigenvalue on $f=0$ is $f_v-\gamma f_u$, so $f_v<0$ alone does not establish attraction. If $v=V(u)$, the slow equation is $\dot{u}=(\mu -u)/(1+\gamma V^{\prime }(u))$. Folds of this reduced description satisfy $V^{\prime }=-1/\gamma$.

A plant calcium sensor, often abbreviated CBL, that works with a CBL-interacting protein kinase. Sensor localization and partner selection help confer response specificity.

A probe whose measurable output depends on calcium ion binding. Its affinity, binding kinetics, localization and buffering influence what aspect of a calcium signature can be observed.

A localized region with calcium concentration differing from the surrounding compartment, for example close to an open ion channel. A whole-cell average can miss such local signals.

Conversion of a calcium signature into downstream molecular activity. A causal decoding mechanism must explain how sensor kinetics, localization and targets distinguish relevant features of the signal.

The binding, activation and inactivation rates through which a calcium sensor transforms a calcium signature. Slow reversal can integrate closely spaced pulses, whereas rapid reversal permits recovery between them.

The temporal and spatial pattern of free intracellular calcium ion concentration during a response, including amplitude, duration, frequency and compartment. Calling a pattern a signature does not establish that it uniquely specifies a stimulus.

Regulation involving production, accumulation and detection of extracellular signals. Signal concentration depends on transport and environment as well as population density.

The Pseudomonas aeruginosa quinolone-signaling network involving HHQ/PQS, PqsR and the pqs biosynthetic locus.

The Pseudomonas aeruginosa RhlI/RhlR system, whose regulation of virulence-factor production is linked to PqsE and the broader signaling network.

The Pseudomonas aeruginosa LasI/LasR acyl-homoserine-lactone signaling system, often upstream of additional quorum-sensing circuits in laboratory strains.

A signalling substance that affects cellular growth, proliferation or survival. A developmental growth effect should be distinguished from arithmetic multiplicative growth.

A mammalian biological growth factor encoded by the Igf2 gene. Parent-of-origin-dependent expression in mice makes it an important experimental system for genomic imprinting.

A bacterial ADP-ribosylating toxin that prevents normal receptor coupling of Gi/o proteins. Its action differs from the persistent active-Gs signalling caused by cholera toxin.

A bacterial toxin whose catalytic component ADP-ribosylates the stimulatory G-protein alpha subunit. Impaired shutoff increases adenylyl-cyclase activity, linking a persistent signal to intestinal ion secretion.

Signalling that connects receptor-associated Janus kinases to STAT transcriptional regulators. In epithelial mosaics, ligand production and response can influence growth of both affected and neighbouring populations.

Stress-responsive signalling involving c-Jun N-terminal kinases. Effects on proliferation, apoptosis and competitive behaviour depend on the experimental context.

Regulation of cellular activity through oxidation-reduction-sensitive processes. A stress-response reporter measures a downstream response and need not directly report the concentration of a particular oxidant.

Signalling by bone morphogenetic proteins, with context-dependent effects on specification, growth and spatial organization. A developmental patterning function is distinct from a generic effect on differentiation.

A developmental signalling system activated by Hedgehog-family ligands. Its outputs depend on the receiving tissue, exposure history and downstream regulatory state.

A small-molecule inhibitor of Hedgehog pathway activity used in experimental patterning studies. Vehicle controls, developmental timing and checks for generalized toxicity are needed when interpreting its effects.

hippo signaling regulates growth-related transcriptional outputs, including the activity and localization of YAP and TAZ. Mechanical inputs can intersect with this network through context-dependent routes.

mechanotransduction converts mechanical input into altered molecular activity or cellular behavior. A causal test separates applied mechanics from accompanying chemical changes and identifies a force-sensitive step.

Dependence of cell-state decisions on forces, deformation or the mechanical environment. Experiments must separate physical input from altered ligand presentation, survival and selection of pre-existing states.

A reciprocal relation in which molecular state changes tissue mechanics and mechanically altered conditions change molecular activity. Time-resolved perturbations distinguish feedback from correlated changes.

Cellular responses to interferon gamma, including context-dependent effects on proliferation and antigen presentation. Loss of responsiveness can contribute to immune-therapy escape.

A cytokine influencing T-cell growth and function, including use in some adoptive-cell-therapy regimens.

A growth- and survival-associated signalling pathway that can be activated by receptor inputs or oncogenic changes in its components.

A signalling cascade connecting RAS-family switches and downstream kinases to regulatory outputs including proliferation and differentiation.

A secreted signalling protein influencing cellular behaviour, especially in immune and tissue responses. Its effect depends on the responding cells and local context.

A cytokine involved in immune and other signalling, including studied effects on neural physiology. Its physiological effects depend on source, target, dose and timing.

Vascular endothelial growth factor, a family of signals that regulate vascular development and function, including angiogenic responses in tumours.

Colony-stimulating factor 1, a signal promoting survival and differentiation within monocyte/macrophage lineages and participating in some tumour–macrophage interactions.

A chemokine also called SDF-1, involved in cell recruitment and stromal–tumour signalling in several experimental settings.

A signalling protein that influences cell recruitment and positioning, often by inducing directed cell movement through a compatible receptor.

A member of a nutrient-responsive GTP-binding regulatory family involved in positioning mTORC1 at the lysosome.

A regulatory complex in nutrient signaling upstream of Rag GTPases and mTORC1.

A leucine-binding sensor upstream of mTORC1. Its nutrient-dependent interaction with GATOR2 helps couple leucine availability to growth signaling.^[ref]

Mechanistic target of rapamycin complex 1, a nutrient-responsive protein kinase complex. Its activity affects initiation through 4E-BP proteins and other substrates, and also regulates autophagy and growth investment.

Bone morphogenetic protein 4, a signalling ligand with developmental functions including induction of mouse primordial germ cells from competent epiblast.

Signalling initiated by leukaemia inhibitory factor, important in some mouse pluripotent-cell culture conditions. A culture dependency is not automatically an embryonic lineage-specification dependency.

A family of signalling pathways with context-dependent developmental and cell-state functions. Ligand, receptor and downstream requirements should be distinguished experimentally.

Developmental signal transduction initiated by Nodal-family ligands, belonging to the broader TGF-beta signalling system.

A kinase upstream of ERK. A failure of a MEK inhibitor to change fate does not alone establish that ERK is dispensable without testing effective pathway inhibition in the embryo.

An adaptor protein linking activated receptors to downstream signalling, including a pathway required for normal mouse hypoblast allocation.

A fibroblast growth factor important in signalling between early mammalian lineages, including promotion of mouse hypoblast development.

A signalling system regulating factors such as YAP. In early mouse embryos it connects cellular position and polarity to lineage-associated transcription.

Extracellular signal-regulated kinase, a kinase downstream of MEK. Phosphorylation and downstream activity must be assayed in the relevant cells when testing inhibitor effects.

A BMP-family signalling ligand in Drosophila melanogaster, including an early dorsal embryonic expression domain repressed ventrally by nuclear Dorsal protein.

Signal transduction initiated by fibroblast growth factors acting through FGF receptors. A major downstream branch involves MEK and ERK, but receptor activation can engage other pathways.

Signal transduction initiated by Wnt-family ligands. Distinct pathway branches regulate gene expression, cell polarity and cell behaviour; their effects depend on developmental context.

A signalling protein involved in canonical Wnt and planar cell polarity pathways. Perturbations can disrupt oriented cell movement without abolishing the associated cell fate.

A signalling system that produces different transcriptional states in sister cells. In the Caenorhabditis elegans EMS division, nuclear POP-1 and SYS-1 levels establish different coactivator-to-transcription-factor ratios.

A member of a secreted signaling-protein family acting through Wnt signalling pathways. Adding ligand need not produce a measurable reporter change if the responding machinery or assay range is unsuitable.

The Wnt ligand participating in the P2-to-EMS interaction during early Caenorhabditis elegans development.

A Wnt-family ligand with a role in dorsal limb patterning through induction of a dorsal transcriptional programme in competent mesenchyme.

A contact-dependent signalling system. During vertebrate somitogenesis, coupling through Notch can coordinate neighbouring oscillators without being identical to the intracellular oscillation mechanism.

A second messenger is a small intracellular molecule or ion that relays a received signal to target proteins. Its production, release, removal or binding changes its availability after signal reception. For a cell-surface receptor, distinguish the extracellular ligand, often called the first messenger, from the intracellular second messenger. An activated relay protein is not thereby a second messenger: the term identifies small chemical mediators, rather than every downstream component of signal transduction. ^[ref]

Two examples clarify what changes. A biological cell can make cAMP from ATP; alternatively, release of stored calcium ions can raise the free calcium concentration in its cytoplasm. The latter need not increase the total calcium content of the biological cell. Availability to target proteins, not merely the total amount present, carries the message. Removal and sequestration help terminate such signals. ^{[ref] [ref]}

The experimental motivation is unusually tangible: can a hormone's effect be transferred to machinery that barely responds to the hormone itself? In Rall, Sutherland and Berthet's 1957 experiment, washed cat-liver particles were incubated with ATP and magnesium ions, with or without epinephrine and glucagon, two hormones. After five minutes at $30{}^{\circ }\mathrm{C}$, the mixtures were heated in boiling water for three minutes, chilled, and separated to remove insoluble material. Small samples of the clarified extracts were transferred to a separate soluble dog-liver preparation, again supplied with ATP and magnesium ions. The readout was the change in glycogen phosphorylase activity over five minutes, not the amount of newly synthesized protein. ^[ref]

The hormone-conditioned extract caused a larger increase in glycogen phosphorylase activity. Water, extract made without hormones, and hormones added directly to the soluble preparation produced smaller effects. These comparisons distinguish transferred activity from baseline activity, preparation effects and simple hormone carryover. ^[ref]

The inference is a transferable, heat-stable intermediary between the hormone-sensitive particles and the soluble machinery. This does not identify the intermediary merely from heat resistance, establish its direct target, or show that every hormone uses the same mechanism. Rall and Sutherland's 1958 paper reports the factor's identification as cAMP in accompanying chemical work, and follows its production from ATP. It also reports an important limit: washed heart and skeletal-muscle particles produced detectable cAMP with epinephrine under their test conditions, whereas brain particles produced similar amounts with and without it. Tissue and preparation matter. ^[ref]

The useful and beautiful separation is between recognition and execution: an extracellular ligand can control intracellular enzymes through a chemically different intermediary. Making many second messenger molecules can support signal amplification, while different target proteins give the same mediator different consequences. A second messenger identifies a mode of relaying information; its presence alone does not specify the size or direction of the response. ^[ref]

In signal transduction, inositol trisphosphate usually means inositol 1,4,5-trisphosphate: a soluble intracellular second messenger. An extracellular ligand, its cell-surface receptor, IP3 and the released calcium ions are distinct components. IP3 binds an IP3 receptor on the endoplasmic reticulum, promoting stored ${\mathrm{Ca}}^{2+}$ release into the cytosol.^[ref]

The useful separation is spatial: an extracellular message can control an internal store without entering it. The existing intracellular-injection experiment under metabotropic receptor tests bypassing reception; the Pancreatic IP3 store fractionation experiment below tests which internal compartment supplies the released calcium. Neither question is answered merely by observing a downstream membrane electric current.

Phospholipase C catalyzes hydrolysis of membrane PIP2, producing soluble IP3 and membrane-associated diacylglycerol. This consumes a phospholipid substrate, rather than manufacturing calcium. G protein-regulated and receptor tyrosine kinase-regulated forms of PLC provide different routes to this reaction.^[ref]

An IP3 receptor is an intracellular ligand-gated ion channel, rather than the extracellular signal's cell-surface receptor. Its opening is regulated by both IP3 and cytosolic calcium: IP3 binding is not a command that fixes one constant release rate. Mammalian IP3 receptors have three subtypes, with possible mixed assemblies and splice variants; these need not have identical regulation or cellular roles. The 2010 authored account distinguishes established channel behavior from then-unresolved structural explanations.^[ref]

An IP3-sensitive calcium store contains releasable calcium behind a membrane bearing functional IP3 receptors. The endoplasmic reticulum is an important example. Pumping calcium into it or exporting calcium across the cell membrane lowers free cytosolic calcium; intracellular redistribution and loss from the whole biological cell are different balances.^[ref]

Finite availability matters: a release pathway cannot deliver more calcium than its accessible store contains unless replenishment occurs. A falling cytosolic calcium response can reflect reduced release, increased removal, or both. Store content, release rate and free cytosolic concentration therefore answer different questions. Binding to proteins can also change the free fraction without changing the total number of calcium ions.

A 1984 primary experiment localized IP3-evoked release using pancreatic acinar cells isolated from rat pancreas with collagenase. A homogenized preparation was separated by differential centrifugation, then by a sucrose step density gradient or precipitation with magnesium chloride. The readout was IP3-induced calcium release per mass of protein across fractions. Release tracked two endoplasmic reticulum markers, RNA content and an enzyme activity, across several separation methods. Marker activities for mitochondria and the cell membrane supplied contrasting comparisons: release correlated negatively with them.^[ref]

Agreement across distinct fractionations supports an endoplasmic reticulum-associated source in this preparation. “Nonmitochondrial” alone only excludes a candidate; positive compartment markers add localization evidence. Marker comparisons control the localization inference, rather than replacing a no-IP3 release comparison. Fractionation may mix or damage compartments, and correlation does not itself identify the IP3 receptor protein. This calcium release readout also does not directly measure secretion or establish identical responses in every biological cell.

For an original mathematical model, imagine a sustained, imposed release pathway, with no store refill during the plotted interval. Let $S$ be releasable store amount of substance, $X$ excess freely dissolved cytosolic calcium amount of substance, and $Q$ the cumulative amount removed from $X$ into a separate sink. Choose $S(0)=1\mathrm{amol}$, $X(0)=Q(0)=0$, cytosolic volume $V_c=1\mathrm{pL}$, release rate constant $k=0.4{\mathrm{s}}^{-1}$ and clearance rate constant $h=0.8{\mathrm{s}}^{-1}$. These are stipulated values, not physiological measurements or a model of IP3 receptor gating.

Assume fixed volume, uniform mixing, no binding, no reverse transfer, no outside entry and first-order loss from each donating compartment. ThenThe last equality is conservation of mass for the tracked calcium across the store, mobile excess and sink together; it does not assert conservation inside a biological cell if the sink represents export. A constant background $c_b=0.1\mu \mathrm{M}$ is held separate from this excess bookkeeping. Since $1\mathrm{amol}/1\mathrm{pL}=1\mu \mathrm{M}$, the response is $c=c_b+X/V_c$.

Solving these ordinary differential equations givesRelease $kS$ declines from the start, yet $X$ initially rises because delivery exceeds clearance. Its peak occurs when $kS=hX$, at $t_{\ast }=\log (h/k)/(h-k)=\log (2)/0.4\approx 1.73\mathrm{s}$. There $X=0.25\mathrm{amol}$ and $c=0.35\mu \mathrm{M}$. Ultimately $S$ and $X$ tend to zero, $Q$ tends to $1\mathrm{amol}$ and $c$ returns to $c_b$. The delayed peak is a consequence of material balance, even though this model has no delayed channel activation.

This distinction guides interpretation: a large released amount need not mean a large simultaneous free cytosolic concentration. Clearance and volume intervene. Real biological cells add binding, store refilling, IP3 turnover and IP3 receptor regulation; the two plotted curves isolate one finite-store effect rather than explaining every calcium response.

Cyclic adenosine monophosphate is a cyclic nucleotide made from ATP. It can serve as an intracellular second messenger, changing the activity of target proteins after a signal has been received. Different biological cells can respond differently because they contain different targets. ^[ref]

Signal amplification is an increase in a specified downstream response relative to an initiating signal. In a molecular-count description, one activated component can generate or activate many downstream molecules. Repeated catalysis by an enzyme supplies a mechanism: the enzyme remains available for another chemical reaction. Successive stages can multiply the response. For a biological example, Cooper describes the epinephrine-to-glycogen phosphorylase pathway, where production of many cAMP molecules and repeated downstream protein phosphorylation provide opportunities for signal amplification. This is an example, not a claim that every signal transduction pathway has the same stages or gain. ^[ref]

Here is a counting toy extending the example under signal transduction. Suppose $N_0$ activated receptors each activate $a=5$ distinct relay proteins during a first interval. During a subsequent interval, each relay activates $b=20$ distinct target proteins. Assume enough inactive relays and targets, no shared targets, and no loss of activity during the count. ThenFor $N_0=1$, this gives $N_1=5$ and $N_2=100$: the target-to-receptor count ratio is $100$. These are assumed integer counts, not measured rates or a universal physiological amplification factor. The intervals are sequential; the equations do not specify a time course.

Availability limits the multiplication. As a second toy assumption, let there be only $T=250$ initially inactive target proteins shared by all branches, and suppose the branches can activate distinct targets until this pool is exhausted. ThenTwo activated receptors give $200$ active targets, whereas three give $250$, not $300$. At three activated receptors, the total count ratio is $250/3\simeq 83.3$; adding a fourth activates no additional targets. Thus total output per input and the increment caused by an extra input are different notions of gain. This finite-pool rule is an illustrative bound, not an enzyme kinetics law.

Signal amplification makes a small initiating signal capable of a larger response, but it does not supply the material or energy for downstream chemical reactions. In the second messenger transfer experiment, both stages still required added ATP and magnesium ions. Counts, changes in concentration, and changes in enzyme activity are different readouts; an amplification claim should name its input, output and observation interval. ^[ref]

A hormone is a chemical messenger released by biological cells that regulates target biological cells bearing suitable receptors. In endocrine signaling, hormones travel to distant targets through the bloodstream. The extract-transfer experiment under second messenger isolates part of this signal transduction from intact biological cells. ^[ref]

A positive test for this hormone does not establish the location or continuing viability of a pregnancy.

An endogenous chemical regulator coordinating plant growth, development or environmental responses. Its effect depends on concentration, tissue and the receiving signal transduction network.

A class of plant signals with developmental roles and functions in the rhizosphere, including stimulation of arbuscular mycorrhizal fungal branching.

A family of growth-regulatory proteins whose degradation is promoted by gibberellin signaling. Direct interactions with phytochrome-interacting factors connect hormone status to light-regulated growth.

A class of plant growth regulators. Gibberellin perception can promote degradation of DELLA proteins, releasing constraints on selected growth responses.

A class of growth regulators whose synthesis, directional transport and perception help organize plant growth. A change in auxin abundance and a change in auxin sensitivity are distinct mechanisms.

Directional cell-to-cell transport of auxin. Transporter abundance, polarity and activity influence local hormone distribution.

A plant hormone involved in water-stress responses, seed dormancy and other processes. In guard cells, ABA-dependent receptor inhibition of phosphatases permits kinase activation and stomatal closure.

A hormone based on a steroid scaffold. Many act through an intracellular nuclear receptor to regulate gene expression.

A steroid hormone involved in physiological regulation and psychological stress responses. Interpretation depends on sampling time, baseline and the challenge being studied; a lower concentration is not automatically a measure of better psychological adaptation.

Adrenaline, also called epinephrine, is an endogenous catecholamine messenger: the body makes it and can release it into blood as a hormone. The adrenal medulla, the inner region of an adrenal gland, secretes adrenaline in response to sympathetic nervous system stimulation. A circulating hormone broadcasts a signal, but each receiving biological cell interprets it through its own receptors and intracellular machinery. Adrenaline activates both alpha-adrenergic receptors and beta-adrenergic receptors; it does not command one identical response everywhere.^[ref][ref]

Fuel mobilization is a useful example. A beta-adrenergic receptor can increase adenylyl cyclase activity through a stimulatory G protein, increasing the intracellular second messenger cAMP. Protein kinase A responds to cAMP; a phosphorylation relay through phosphorylase kinase activates glycogen phosphorylase, favoring glycogenolysis. Here adrenaline is the extracellular message, cAMP is the intracellular message, and glycogen is the reserve being mobilized. These are three different roles.^{[ref][ref][ref]}

The two reserves provide different material. Glycogenolysis draws on glycogen; lipolysis breaks down stored triglycerides, releasing fatty acids and glycerol. A skeletal muscle biological cell's own reserve and fuel released by adipose tissue are different supplies. Increasing a signal cannot mobilize an empty reserve: receptor activation changes the use of available material rather than creating fuel. The adrenergic adipocyte assay below gives direct human evidence for the lipolysis branch.^[ref]

Receptor context can even oppose this branch. In the human adipocyte preparation below, beta-adrenergic receptors promoted cAMP accumulation, whereas alpha-2 adrenergic receptors opposed it. Alpha-1 adrenergic receptors were associated with a different phospholipid readout. The balance of these responses matters more than the name of the messenger alone.^[ref]

This separation is useful when explaining signal transduction: ask which receptor is present, which relay it controls, which reserve or target is available, and which response was actually measured. Receptor binding occupancy, second messenger production and final fuel release are distinct observations. A stronger cAMP signal need not imply an equally large change in every downstream process; substrate availability and the rest of the receiving biological cell still matter.

The extract-transfer experiment under second messenger supplies the earlier experimental separation between hormone reception and an intracellular intermediary. Its existing account includes the preparations and controls. The complementary adrenergic adipocyte assay asks a different question: can the same adrenaline stimulus engage opposing receptors within a human preparation?

In the 1981 study, investigators incubated human adipocytes or their cell membranes from fat near the abdominal lining with epinephrine. They combined detection of bound ligands by radioactive decay with biochemical readouts: adenylyl cyclase activity, cAMP and released glycerol. Blocking alpha-2 adrenergic receptors increased the epinephrine response; blocking alpha-1 adrenergic receptors did not. A separate labeled-phosphate incorporation readout in a phospholipid showed the reverse blocker sensitivity. Thus the comparisons separated response branches.^[ref]

The glycerol readout indicates lipolysis, rather than directly measuring whole-body fuel use. Isolated adipocytes omit circulation and nervous input; blocker selectivity also limits the inference. These comparisons support receptor-specific responses in that preparation, not identical behavior in all biological cells.

Glucagon is a peptide hormone made by alpha cells in the pancreatic islets. Its mature polypeptide has 29 amino acid residues. Alpha cells store glucagon in secretory granules and release it by exocytosis. Glucagon is a message about fuel availability; glucose is the sugar whose supply it helps regulate. A falling blood glucose concentration favors glucagon release, whereas a rise usually suppresses it. Amino acids can also stimulate release, so a meal containing protein need not produce the same hormone pattern as a meal dominated by carbohydrates. ^[ref]

The principal blood glucose-raising target is the liver. In a hepatocyte, the glucagon receptor is a G protein-coupled receptor: activation of a stimulatory G protein drives adenylyl cyclase, increasing the second messenger cAMP and activating protein kinase A. Downstream phosphorylation, including the phosphorylase kinase relay to glycogen phosphorylase, favors glycogenolysis. Glucagon also supports gluconeogenesis. These are different supplies: glycogenolysis draws on a finite glycogen reserve, whereas gluconeogenesis makes glucose from other substrates and depends on their availability. Longer fasting depletes the glycogen reserve; a stronger hormone signal cannot release material that is no longer there. ^{[ref] [ref]}

Do not copy the liver pathway into every target of insulin. Skeletal muscle uses its own glycogen reserve locally; its glucose uptake and the liver's glucose output are different flows. Nor is direct glucagon-stimulated lipolysis in human adipose tissue as firmly established as its action in the liver. Glucagon action depends on the tissue, other hormones, and available substrates. ^[ref]

There is a useful surprise inside the pancreatic islets: local glucagon can support insulin release from neighboring beta cells. The islet perifusion experiment distinguishes that interaction from glucagon's action on the liver. Thus the two hormones can oppose each other's effects on blood glucose while cooperating locally. Delta cells supply another local brake through somatostatin. ^{[ref] [ref]}

Intraislet glucagon signaling is critical for maintaining glucose homeostasis by Lu Zhu and others tested whether local glucagon supports insulin release. For human pancreatic islets, a computer-controlled flow system delivered a buffer solution at $1\mathrm{ml}/\min$ through a chamber holding 500 pancreatic islets on a nylon filter at $37{}^{\circ }\mathrm{C}$. A fraction collector sampled the outgoing fluid. With an amino acid mixture present, the experiment changed glucose from $3$ to $16.7\mathrm{mM}$ and compared GLP-1 receptor blockade with fluid lacking the blocker. The readout was released insulin and glucagon: blockade reduced glucose-stimulated insulin release without significantly changing glucagon release. ^[ref]

Complementary mouse experiments suppressed alpha cell activity using an engineered G protein-coupled receptor. ELISA assays of minute-by-minute effluent samples measured insulin and glucagon concentrations, providing the hormone release readout. Drug-treated control pancreatic islets lacking that engineered receptor checked for drug effects; adding glucagon restored insulin release in the suppressed preparation. Together, blockade and rescue support local signal transduction from alpha cells to beta cells. Isolated pancreatic islets omit intact circulation and nervous input; the human preparation came from five donors, and blocker specificity and donor variation limit generalization. A chamber response does not directly measure whole-body blood glucose control. ^[ref]

Signaling feedback returns the effect of a downstream event to an earlier stage of signal transduction, closing a loop analogous to feedback control. Trace the causal arrows: if an earlier relay activates a later relay and the later relay changes the earlier relay's activity, the return path closes the loop. Negative feedback opposes the initiating change; positive feedback reinforces it. Signaling feedback is a possible property of signal transduction, not a requirement of every pathway.

For a schematic example, let relay $A$ activate relay $B$. If $B$ inhibits $A$, increased $A$ eventually produces an opposing influence: negative feedback. If $B$ activates $A$, increased $A$ produces a reinforcing influence: positive feedback. These signs describe effects on activity, rather than the direction in which molecules travel. A closed loop containing two inhibitions can have positive feedback, because inhibiting an inhibitor reinforces the original change. The sign belongs to the whole loop.

Negative feedback can restrain excessive activation and help preserve a usable range of responses. Positive feedback can support a decisive transition: Alberts and colleagues describe an enzyme whose product increases its own activity. Such reinforcement can contribute to switchlike behavior, but a positive feedback arrow alone does not prove bistability. A different structure, an incoherent feedforward loop, sends opposing influences forward from the same input; inhibition there is not a downstream return. ^{[ref] [ref]}

A worked mathematical model shows why negative feedback does not automatically produce complete signaling adaptation. Let $s$ be a fixed normalized input, $r$ a normalized response, $g\ge 0$ a dimensionless feedback gain, and $\tau >0$ a time constant. Suppose response removal contributes $-r$ and a return proportional to the response contributes $-gr$. The ordinary differential equation isSetting the derivative to zero gives the equilibrium point $r_{\ast }=s/(1+g)$. A displacement $\delta r=r-r_{\ast }$ obeys $\tau d(\delta r)/dt=-(1+g)\delta r$, so its decaying exponential function establishes asymptotic stability. For a unit input switched on at $t=0$, initial condition $r(0)=0$, $g=2$ and $\tau =1$ second,The negative feedback reduces the eventual response from $1$ to $1/3$, but this response rises monotonically and never returns to its zero baseline. Attenuation and complete signaling adaptation are different properties. This deliberately simple mathematical model specifies no molecular pathway; integral action provides a contrasting way to remove a lasting offset in a stable feedback control system. ^[ref]

Negative feedback closes a causal loop whose net effect opposes an initiating change. In signal transduction, activation followed by a downstream inhibition of the earlier activating stage is one example of negative feedback. Loop sign alone does not establish asymptotic stability or complete signaling adaptation; see the worked signaling feedback example.

A useful biological example is chemotaxis feedback regulation: an Escherichia coli biological cell adjusts its response to a sustained attractant instead of remaining at its immediate response. Increased CheA activity promotes CheB phosphorylation; CheB reverses receptor methylation, opposing their activation. After attractant addition, reduced activity instead favors receptor methylation by CheR, restoring activity. This is a return from receptor activity to the machinery regulating that activity. The response need not return exactly at every dose. ^[ref]

A motivating measurement is the chemotaxis FRET assay. CheY and CheZ carrying yellow and cyan fluorescent tags were observed in immobilized Escherichia coli biological cells on a coverslip in a flow chamber. Adding and removing attractant changed the yellow-to-cyan emission ratio, reporting the association of phosphorylated CheY with CheZ. This measures a molecular readout upstream of motor behavior. Comparisons with biological cells lacking CheR, CheB, or both tested the dependence on receptor modification; these perturbations also change starting activity and sensitivity, so they are not pure changes of one feedback gain. ^[ref]

The later chemotaxis feedback regulation experiment used only the Tar receptor and nonmetabolizable methylaspartate, supplied and removed by flow. Long recordings separated slow recovery from incomplete signaling adaptation; correction for bleaching addressed drift in the optical readout. Activity recovered incompletely after sufficiently large additions, with detectable imprecision already at $10\mu \mathrm{M}$ in that preparation. Restricting the receptor type and preventing consumption of the stimulus help interpret the perturbation, but limit transfer to other receptors and conditions. The readout infers CheA activity through CheY-CheZ association, rather than directly measuring every molecular step. ^[ref]

Negative feedback can also overshoot or sustain oscillations if its return arrives too late. The worked signaling feedback example gives the contrasting instantaneous case; the delayed negative feedback model below isolates the effect of timing. Loop sign describes causation, while asymptotic stability describes what happens to displacements over time.

A feedback delay is a time interval between an event and its returning influence. Multiple biochemical steps can introduce an effective lag; a fixed delay is an idealization, not a universal description of signal transduction. To isolate timing, let $x$ be a signed displacement from an equilibrium point and use normalized dimensionless variables:The local removal is $-x$ and the returning influence is negative at every delay. At $d=0$ the ordinary differential equation reduces to the decay already illustrated under signaling feedback. For $d>0$ a delay differential equation requires a history on $[-d,0]$, not just an initial condition at one instant. Negative values of $x$ are displacements, not negative chemical concentrations.

An exponential function $x=e^{\lambda t}$ gives the characteristic equation of a delay differential equationPutting $\lambda =i\omega$ and equating real and imaginary parts gives $\cos (\omega d)=-1/2$ and $\omega =2\sin (\omega d)$. The first crossing with $\omega >0$ therefore occurs atFor this particular mathematical model, the equilibrium point is asymptotically stable for $0\le d<d_c$. No nonnegative real delayed feedback characteristic root can satisfy the equation; the first loss of asymptotic stability is the indicated pair of imaginary delayed feedback characteristic roots. Differentiating the characteristic equation of a delay differential equation along a root yieldsThus the pair moves into growth as the delay increases through $d_c$. The neutral mode at $d_c$ is a periodic function, but its amplitude depends on history: this linear mathematical model does not select an attracting limit cycle.

The figure plots $x(t)=e^{at}\cos (bt)$ using a delayed feedback characteristic root $\lambda =a+ib$ and that same formula on the history interval. At $d=0.7$ the displayed mode decays; at $d=1.5$ it grows. These are exact modes up to numerical root accuracy, not step responses with identical histories. Molecular bounds and a changed return law would be needed to interpret what happens after an unstable biological response becomes large.

A delayed feedback characteristic root solves the characteristic equation of a delay differential equation and supplies an exponential function mode. Its real part determines decay or growth of that mode.

In Escherichia coli, chemotaxis feedback regulation couples receptor activity to modification of the receptors by CheR and CheB. It is a molecular example of negative feedback supporting signaling adaptation, with precision and kinetics assessed by the chemotaxis FRET assay above.

Removal of methyl groups from a modified receptor. In chemotaxis feedback regulation, this reverses the chemical modification introduced by receptor methylation; the two processes have different enzyme-dependent rates. Whether the demethylation rate depends on total receptor modification or on active receptors matters for perfect adaptation.

A conceptual chemotaxis adaptation model in which saturated CheR action supplies receptor methylation while CheB preferentially demethylates active receptors. If $\dot{M}=r-bA/(K+A)$, the steady state output is $A_{\ast }=Kr/(b-r)$, independent of ligand whenever a physically accessible stable steady state exists. Changing enzyme abundance can change this baseline without destroying adaptation to a subsequent ligand step.^[ref]

If the forward receptor-modification flux depends on remaining unmethylated substrate, it generally depends indirectly on ligand through the modified receptor pool. The steady output then need not be ligand independent. Near-perfect adaptation may remain in a saturation limit; finite modification capacity and completely inactive receptor populations also bound the ideal perfect-adaptation result.

Return of an output to its original steady value after a persistent input change, with the adaptation property persisting over a range of model parameters. integral action can implement this property under stability and operating-range assumptions.